Bioventus Inc. (BVS) vs Tandem Diabetes Care, Inc. (TNDM)
Bioventus Inc. and Tandem Diabetes Care, Inc. are both Medical Devices companies. Bioventus Inc. and Tandem Diabetes Care, Inc. are of similar size ($1.1B and $1.1B). Tandem Diabetes Care, Inc. has negative trailing earnings, so its P/E is not meaningful; Bioventus Inc. trades at 17.0×. Tandem Diabetes Care, Inc. grew revenue faster over the last twelve months: 3.96% against 3.14%. Bioventus Inc. has the higher net margin (9.36% vs −6.08%) and the higher return on invested capital (7.34% vs −10.3%). Across the 19 metrics below, Bioventus Inc. leads on 13 and Tandem Diabetes Care, Inc. on 6.
Valuation
Profitability
| Metric | BVS | TNDM | Medical Devices median |
|---|---|---|---|
| Gross margin | 68.65% | 56.01% | 56.01% |
| Operating margin | 10.02% | (4.40%) | (15.03%) |
| Net margin | 9.36% | (6.08%) | (20.40%) |
| Free cash flow margin | 16.20% | (2.56%) | (7.24%) |
| Return on equity | 22.75% | (48.03%) | (15.32%) |
| Return on assets | 7.89% | (6.24%) | (19.72%) |
| Return on invested capital | 7.34% | (10.33%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack